| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1003684761 |
| P356 | DOI | 10.2165/00003088-198815010-00001 |
| P698 | PubMed publication ID | 3042243 |
| P50 | author | Darrell Abernethy | Q18977896 |
| P2093 | author name string | Schwartz JB | |
| P2860 | cites work | The mechanism of action of calcium antagonists relative to their clinical applications | Q28299968 |
| Noncompartmental Determination of the Steady‐State Volume of Distribution | Q34218917 | ||
| History of calcium antagonists | Q34256195 | ||
| First-pass elimination. Basic concepts and clinical consequences | Q34257205 | ||
| Nimodipine disposition and haemodynamic effects in patients with cirrhosis and age-matched controls | Q34416479 | ||
| Effect of nicardipine in elderly hypertensive patients | Q34446952 | ||
| An investigation of the cause of accumulation of verapamil during regular dosing in patients | Q34622637 | ||
| Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects | Q34713722 | ||
| Calcium-antagonist drugs. Receptor interactions that clarify therapeutic effects | Q38153391 | ||
| Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders | Q39658484 | ||
| Clinical pharmacokinetics of verapamil, nifedipine and diltiazem | Q39754378 | ||
| Nitrendipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension | Q39764429 | ||
| Pharmacology of calcium entry blockers: interaction with vascular alpha-adrenoceptors | Q40090453 | ||
| The heterogeneity of the slow channel blockers (calcium antagonists). | Q40155824 | ||
| The current status of the mechanism of the calcium channel antagonists | Q40337345 | ||
| The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily | Q41855699 | ||
| Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique | Q42126042 | ||
| The metabolism of nicardipine hydrochloride in healthy male volunteers | Q42221085 | ||
| Pharmacokinetics of (+)-, (-)- and (+/-)-verapamil after intravenous administration | Q42532060 | ||
| The metabolism and pharmacokinetics of nicardipine hydrochloride in man. | Q43240255 | ||
| Commentary: a physiological approach to hepatic drug clearance | Q43996648 | ||
| Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans | Q45009348 | ||
| Effects of amlodipine on steady-state digoxin concentrations and renal digoxin clearance. | Q46511287 | ||
| Pharmacokinetics of nimodipine in patients with aneurysmal subarachnoid haemorrhage | Q48398671 | ||
| Effect of two different meals on bioavailability of nilvadipine in healthy volunteers. | Q51629936 | ||
| Pharmacokinetics of nilvadipine in healthy volunteers. | Q51630558 | ||
| Bias in pharmacokinetics and clinical pharmacology. | Q52871207 | ||
| Felodipine kinetics in healthy men. | Q54117719 | ||
| Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage. | Q54242490 | ||
| Pharmacokinetic, haemodynamic and radionuclide studies with nicardipine in coronary artery disease. | Q54435825 | ||
| Plasma protein binding and erythrocyte partitioning of nicardipine in vitro | Q68943517 | ||
| Plasma protein binding of nilvadipine, a new dihydropyridine calcium antagonist, in man and dog | Q68974693 | ||
| Bioavailability and elimination of nitrendipine in liver disease | Q69397308 | ||
| Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: an overview | Q69567234 | ||
| Comparative pharmacokinetics and cardiovascular effects of tiapamil in healthy volunteers and patients with hepatic cirrhosis | Q69749399 | ||
| Pharmacokinetics and metabolism of calcium-blocking agents nifedipine, nitrendipine, and nimodipine | Q69773592 | ||
| Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituents | Q70010575 | ||
| The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humans | Q70046808 | ||
| Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationship | Q70085984 | ||
| Absorption, distribution and elimination of felodipine in man | Q70087050 | ||
| Pharmacokinetics and metabolism of tiapamil | Q70538742 | ||
| Metabolic fate of nicardipine hydrochloride, a new vasodilator, by various species in vitro | Q70711545 | ||
| Pharmacokinetic studies on nicardipine hydrochloride, a new vasodilator, after repeated administration to rats, dogs and humans | Q70711550 | ||
| Clinical pharmacokinetics of nimodipine in normal and impaired renal function | Q70735893 | ||
| Pharmacokinetics of nicardipine following oral and intravenous administration in man | Q70759563 | ||
| Interaction between digoxin and the calcium antagonists nicardipine and tiapamil | Q71063196 | ||
| Nifedipine: kinetics and dynamics in healthy subjects | Q71388551 | ||
| Pharmacokinetics of nitrendipine in patients with renal failure: comparison to normal subjects | Q72383333 | ||
| Steady-state pharmacokinetics of nitrendipine in hepatic insufficiency | Q72383337 | ||
| Verapamil competitively inhibits alpha 1-adrenergic and muscarinic but not beta-adrenergic receptors in rat myocardium | Q72668537 | ||
| Effects of d,l-verapamil on atrioventricular conduction in relation to its stereoselective first-pass metabolism | Q93571513 | ||
| Study of nifedipine photodecomposition in plasma and whole blood using capillary gas-liquid chromatography | Q93616825 | ||
| P433 | issue | 1 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| P304 | page(s) | 1-14 | |
| P577 | publication date | 1988-07-01 | |
| P1433 | published in | Clinical Pharmacokinetics | Q5133788 |
| P1476 | title | Pharmacokinetics of calcium antagonists under development | |
| P478 | volume | 15 |
Search more.